BioNTech aims to create a fully integrated, enterprise-wide capability to discover, design and develop next-generation immunotherapies at scale by leveraging data and AI technologies across the value chain - be it in in silico drug discovery, AI-optimized clinical trial protocols or predictive maintenance in manufacturing. In this session, you will learn how BioNTech is building a data and AI platform and driving organizational change with a decentralized data mesh approach. You will also gain an insight into the technological concepts of the platform that enables the teams at BioNTech to develop, deploy and operate digital products for data value creation.